Although DNA copy number abundance of EGFR and ERBB2 had been studied independently [23, 24], the associations between EGFR-activating mutations, whole ErbB family, and clinical prognosis in lung cancer were still needed to be investigated. The gene discussed is EGFR; the disease is lung carcinoma.